On the 12th of June 2012 I attended a summit organised by The International Association of Physicians in AIDS Care (IAPAC) and the British HIV Association (BHIVA). It focused on implementation challenges and opportunities of biomedical prevention, TasP and pre-exposure prophylaxis (PrEP), and was titled “Controlling the HIV Epidemic with Antiretrovirals”. The conference facilitated discussion on the use of …
Treatment as Prevention: recognising the creative potential of antiretroviral medications
This article is part of the series: Social Dynamics of Biomedical Prevention, Transcriptions Series